Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03399500 · ClinicalTrials.gov registry record · Phase 3

Homeless Care Management App

A Phase 3 study of Substance Use Disorders and Health Behavior, sponsored by University of Oklahoma.

Completed
Registry status
Phase 3
Development phase
403
Enrollment target
2
Study locations

NCT03399500: Completed Phase 3 study of Substance Use Disorders and Health Behavior, sponsored by University of Oklahoma.

NCT03399500 is a Phase 3 study of Substance Use Disorders and Health Behavior that has completed, run by University of Oklahoma. The registered enrollment target is 403 participants, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (19% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03399500, a Phase 3 study of Substance Use Disorders and Health Behavior, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
Phase 3
Development phase
403 participants
Enrollment target
2
Study locations

Study Summary

There is a significant revolving door of incarceration among homeless adults, a population with substantial health disparities. Homeless adults who receive the professional coordination of individualized care (i.e., case management) during the period following their release from jail experience fewer mental health and substance use problems, are more likely to obtain stable housing, and are less likely to be re-incarcerated. The proposed study will use mobile technology to address these barriers and fill gaps in the understanding of the causes of the revolving door of homeless incarceration. This research represents a step toward integrated service connection and healthcare service provision for one of the most underserved, high need, and understudied populations in the United States. Smart phone apps that increase the use of available healthcare services and identify predictors of key outcomes (e.g., homelessness, re-arrest, medication compliance) could be used to reach hard to reach populations with histories of significant and persistent health disparities (e.g., homeless adults).

Primary Outcome

Total number of sessions completed between the randomization visit and 6-month follow-up

Interventions

  • BEHAVIORAL In-Person Case Management at Homeless Recovery Program
  • BEHAVIORAL Unlimited Smartphone
  • BEHAVIORAL Smartphone Based Case Management (SPCM) app

Study Locations (2)

Oklahoma

  • University of Oklahoma Health Sciences Center - OTRC - Oklahoma City

Texas

  • UTHealth School of Public Health - Dallas

Trial Details

FieldValue
Enrollment Target 403 participants
Start Date 2018-04-27
Est. Completion 2023-11-14
Phase Phase 3
University of Oklahoma

358 total trials

What the finished NCT03399500 record still lists

NCT03399500 is an interventional study that assigns participants to a tested intervention. The registered 403 participants enrollment target is mid-sized for trials with a published cap, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (19% lower).

The record links to 4 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 3 interventions - of which In-Person Case Management at Homeless Recovery Program is the first listed.

NCT03399500 reports a single indexed study location in Oklahoma, Texas.

Frequently Asked Questions

What is clinical trial NCT03399500 about?

NCT03399500 is a clinical study titled "Homeless Care Management App". There is a significant revolving door of incarceration among homeless adults, a population with substantial health disparities. Homeless adults who receive the professional coordination of individualized care (i.e., case management) during the period following their release from jail experience fewe...

What is the current status of trial NCT03399500?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 403 participants. The study started on 2018-04-27. Estimated completion is 2023-11-14.

What conditions does trial NCT03399500 study?

This clinical trial studies the following conditions: Substance Use Disorders, Health Behavior, Adherence, Patient, Mental Health Impairment.

What interventions are being tested in trial NCT03399500?

The interventions under investigation include: In-Person Case Management at Homeless Recovery Program (BEHAVIORAL), Unlimited Smartphone (BEHAVIORAL), Smartphone Based Case Management (SPCM) app (BEHAVIORAL).

Who is sponsoring clinical trial NCT03399500?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03399500 being conducted?

This trial has 2 study locations across Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03399500's enrollment target sits among peer trials

403 10th of 93 higher than 84 of 93 other Substance Use Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05647122 · 403 participants · Phase 1

    First in Human Study of AZD9592 in Solid Tumors

  • NCT05674799 · 403 participants · NA

    NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

  • NCT06244771 · 403 participants · Phase 1

    A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  • NCT05049057 · 404 participants · Phase 2

    Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03399500, the US trial registry maintained by the National Library of Medicine. NCT03399500 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.